Even as the New England Journal of Medicine reported the possibility of bird flu strains developing resistance to Tamiflu, another step in the endeavor to find a remedy for the looming pandemic has been taken. China has started human trials of its homespun bird flu vaccine with six volunteers receiving shots. Per reports, volunteers did not experience any bad reaction to the vaccine. Although the trials will encompass another nine months of tests, initial results are expected within the first three. China, which has had more than 30 outbreaks of the deadly H5N1 strain and six confirmed fatalities from the infection, started the development of this vaccine called Panflu last year.
Elsewhere, in Kazakhastan, the health ministry has taken several preventive measures to ward off the threat of bird flu in the country over the next few months. Per the health minister, The government has provided 63 ml tenge from the reserve and today we procure the only efficient anti-infective agents for the time being. We believe that the delivery will take place next year. This is in keeping with the views of experts of the World Health Organization that Kazakhstan has a very high level of preparation for probable bird flu pandemic.
In India too, the contingency plan to be undertaken in the event of an outbreak of avian influenza in the country has been outlined. Steps such as surveillance of the local community, multi-disciplinary rapid response teams by National Institute of Communicable Diseases (NICD), laboratory preparedness for quick testing of samples and logistic and supplies, etc, have been proposed against the virus by the Health Ministry.
Technorati Tags : avian+flu